Rockefeller Capital Management L.P. Agios Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$17.06 - $31.42 $358 - $659	21 Added 21.65%	118 $2,000
Q1 2022 May 13, 2022	SELL	$26.68 - $34.81 $2,054 - $2,680	-77 Reduced 44.25%	97 $2,000
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $5,146 - $8,661	174 New	174 $5,000
Q2 2021 Aug 10, 2021	SELL	$52.06 - $61.27 $4,529 - $5,330	-87 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$31.52 - $53.81 $1,607 - $2,744	-51 Reduced 36.96%	87 $3,000
Q4 2019 Feb 07, 2020	BUY	$30.08 - $50.59 $4,151 - $6,981	138 New	138 $7,000
Q2 2019 Aug 09, 2019	SELL	$46.17 - $68.1 $82,228 - $121,286	-1,781 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$45.92 - $67.67 $2,204 - $3,248	48 Added 2.77%	1,781 $120,000
Q3 2018 Nov 02, 2018	BUY	$71.67 - $91.95 $124,204 - $159,349	1,733 New	1,733 $134,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.